AU685055B2
(en)
*
|
1992-05-29 |
1998-01-15 |
Rockefeller University, The |
Method and product for the sequence determination of peptides using a mass spectrometer
|
US5605798A
(en)
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
US6194144B1
(en)
|
1993-01-07 |
2001-02-27 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
DE4408533A1
(de)
|
1994-03-14 |
1995-09-28 |
Hoechst Ag |
PNA-Synthese unter Verwendung einer basenlabilen Amino-Schutzgruppe
|
US6428955B1
(en)
|
1995-03-17 |
2002-08-06 |
Sequenom, Inc. |
DNA diagnostics based on mass spectrometry
|
US5830655A
(en)
|
1995-05-22 |
1998-11-03 |
Sri International |
Oligonucleotide sizing using cleavable primers
|
US6022688A
(en)
|
1996-05-13 |
2000-02-08 |
Sequenom, Inc. |
Method for dissociating biotin complexes
|
US5886165A
(en)
*
|
1996-09-24 |
1999-03-23 |
Hybridon, Inc. |
Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments
|
US6140053A
(en)
*
|
1996-11-06 |
2000-10-31 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry via exonuclease degradation
|
US6133436A
(en)
*
|
1996-11-06 |
2000-10-17 |
Sequenom, Inc. |
Beads bound to a solid support and to nucleic acids
|
CA2268740C
(en)
|
1996-11-06 |
2010-07-20 |
Sequenom, Inc. |
High density immobilization of nucleic acids
|
US20030129589A1
(en)
*
|
1996-11-06 |
2003-07-10 |
Hubert Koster |
Dna diagnostics based on mass spectrometry
|
US6110676A
(en)
*
|
1996-12-04 |
2000-08-29 |
Boston Probes, Inc. |
Methods for suppressing the binding of detectable probes to non-target sequences in hybridization assays
|
WO1998033939A1
(fr)
*
|
1997-01-31 |
1998-08-06 |
Hitachi, Ltd. |
Procede pour determiner une sequence de base d'acide nucleique et appareil correspondant
|
GB9710582D0
(en)
|
1997-05-22 |
1997-07-16 |
Oxford Glycosciences Uk Ltd |
A method for de novo peptide sequence determination
|
US6962778B1
(en)
|
1997-09-25 |
2005-11-08 |
Boston Probes, Inc. |
Methods, kits and compositions for suppressing the binding of detectable probes to non-target sequences in hybridization assays
|
US6485901B1
(en)
|
1997-10-27 |
2002-11-26 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to linear beacons
|
AU1366299A
(en)
*
|
1997-10-27 |
1999-05-17 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to pna molecular beacons
|
US6268131B1
(en)
|
1997-12-15 |
2001-07-31 |
Sequenom, Inc. |
Mass spectrometric methods for sequencing nucleic acids
|
US6326479B1
(en)
|
1998-01-27 |
2001-12-04 |
Boston Probes, Inc. |
Synthetic polymers and methods, kits or compositions for modulating the solubility of same
|
WO1999049293A2
(en)
|
1998-03-24 |
1999-09-30 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to detection complexes
|
US6723564B2
(en)
|
1998-05-07 |
2004-04-20 |
Sequenom, Inc. |
IR MALDI mass spectrometry of nucleic acids using liquid matrices
|
US7981599B1
(en)
|
1998-07-31 |
2011-07-19 |
Boston Probes, Inc. |
Non-nucleic acid probes, probe sets, methods and kits pertaining to the detection of individual human chromosomes X, Y, 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 16, 17, 18 and 20 as 13/21 as a pair
|
US6441152B1
(en)
|
1998-12-08 |
2002-08-27 |
Boston Probes, Inc. |
Methods, kits and compositions for the identification of nucleic acids electrostatically bound to matrices
|
AU2001251115A1
(en)
|
2000-03-31 |
2001-10-15 |
Trustees Of Boston University |
Use of locally applied dna fragments
|
US6451588B1
(en)
*
|
2000-06-30 |
2002-09-17 |
Pe Corporation (Ny) |
Multipartite high-affinity nucleic acid probes
|
US6963807B2
(en)
|
2000-09-08 |
2005-11-08 |
Oxford Glycosciences (Uk) Ltd. |
Automated identification of peptides
|
US20020090626A1
(en)
|
2000-09-26 |
2002-07-11 |
Hyldig-Nielsen Jens J. |
Probes, probe sets, methods and kits pertaining to the detection, identification and/or enumeration of bacteria
|
EP1356113B1
(de)
*
|
2000-12-15 |
2012-07-18 |
Life Technologies Corporation |
Verfahren zum nachweis von organismen
|
US20040121310A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in forensic studies
|
US7718354B2
(en)
*
|
2001-03-02 |
2010-05-18 |
Ibis Biosciences, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US20030027135A1
(en)
|
2001-03-02 |
2003-02-06 |
Ecker David J. |
Method for rapid detection and identification of bioagents
|
US20040121314A1
(en)
*
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in containers
|
US20040121313A1
(en)
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in organs for transplantation
|
US7666588B2
(en)
|
2001-03-02 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
|
US7226739B2
(en)
|
2001-03-02 |
2007-06-05 |
Isis Pharmaceuticals, Inc |
Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
|
CA2439750A1
(en)
|
2001-03-09 |
2002-09-19 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
|
ATE527376T1
(de)
|
2001-05-18 |
2011-10-15 |
Boston Probes Inc |
Pna-sonden, sondensätze, verfahren und kits im zusammenhang mit dem nachweis von candida
|
US7217510B2
(en)
|
2001-06-26 |
2007-05-15 |
Isis Pharmaceuticals, Inc. |
Methods for providing bacterial bioagent characterizing information
|
US8073627B2
(en)
|
2001-06-26 |
2011-12-06 |
Ibis Biosciences, Inc. |
System for indentification of pathogens
|
US6800449B1
(en)
|
2001-07-13 |
2004-10-05 |
Syngenta Participations Ag |
High throughput functional proteomics
|
JP2005524384A
(ja)
|
2001-09-24 |
2005-08-18 |
ボストン プローブス,インコーポレイテッド |
ゲノム核酸におけるランダム分布反復配列への検出可能なプローブ結合の抑制に関する方法、キットおよび組成物
|
AU2003230717A1
(en)
*
|
2002-03-21 |
2003-10-08 |
Boston Probes, Inc. |
Pna oligomers, oligomers sets, methods and kits pertaining to the detection of bacillus anthracis
|
US20030211509A1
(en)
*
|
2002-03-26 |
2003-11-13 |
Wiley Steven R. |
TNF-delta ligand and uses thereof
|
CA2484010A1
(en)
*
|
2002-05-17 |
2003-12-04 |
Applera Corporation |
Pna probes, probe sets, methods and kits pertaining to the determination of listeria
|
ATE449103T1
(de)
|
2002-09-08 |
2009-12-15 |
Applera Corp |
Festphasengebundene pna-dimere und deren synthese
|
US20040259132A1
(en)
*
|
2002-11-22 |
2004-12-23 |
Henrik Stender |
Peptide nucleic acid probes for analysis of pseudomonas (sensu stricto)
|
JP2006516193A
(ja)
|
2002-12-06 |
2006-06-29 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
ヒトおよび動物における病原体の迅速な同定方法
|
EP2500440B1
(de)
|
2002-12-20 |
2015-12-16 |
Celera Corporation |
Mit Myokardinfarkt assoziierte genetische Polymorphismen, Nachweisverfahren und deren Verwendungen
|
US8046171B2
(en)
|
2003-04-18 |
2011-10-25 |
Ibis Biosciences, Inc. |
Methods and apparatus for genetic evaluation
|
US8057993B2
(en)
|
2003-04-26 |
2011-11-15 |
Ibis Biosciences, Inc. |
Methods for identification of coronaviruses
|
US7964343B2
(en)
|
2003-05-13 |
2011-06-21 |
Ibis Biosciences, Inc. |
Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US8158354B2
(en)
|
2003-05-13 |
2012-04-17 |
Ibis Biosciences, Inc. |
Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US8097416B2
(en)
|
2003-09-11 |
2012-01-17 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US8546082B2
(en)
|
2003-09-11 |
2013-10-01 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US7956175B2
(en)
|
2003-09-11 |
2011-06-07 |
Ibis Biosciences, Inc. |
Compositions for use in identification of bacteria
|
CA2832293C
(en)
|
2003-11-26 |
2015-08-04 |
Celera Corporation |
Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
|
US7666592B2
(en)
*
|
2004-02-18 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for concurrent identification and quantification of an unknown bioagent
|
US8119336B2
(en)
|
2004-03-03 |
2012-02-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of alphaviruses
|
WO2005111235A2
(en)
*
|
2004-05-04 |
2005-11-24 |
Dak Denmark A/S |
Methods for detecting chromosome aberrations
|
CA2852855C
(en)
|
2004-05-07 |
2016-07-05 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
|
CA2567839C
(en)
*
|
2004-05-24 |
2011-06-28 |
Isis Pharmaceuticals, Inc. |
Mass spectrometry with selective ion filtration by digital thresholding
|
US20050266411A1
(en)
|
2004-05-25 |
2005-12-01 |
Hofstadler Steven A |
Methods for rapid forensic analysis of mitochondrial DNA
|
WO2006016978A1
(en)
*
|
2004-06-30 |
2006-02-16 |
Applera Corporation |
Analog probe complexes
|
US7811753B2
(en)
|
2004-07-14 |
2010-10-12 |
Ibis Biosciences, Inc. |
Methods for repairing degraded DNA
|
WO2006135400A2
(en)
|
2004-08-24 |
2006-12-21 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification of recombinant organisms
|
WO2007044031A2
(en)
*
|
2004-12-06 |
2007-04-19 |
Bioveris Corporation |
Methods and compositions for detecting bacillus anthracis
|
US20060292586A1
(en)
*
|
2004-12-17 |
2006-12-28 |
Schroth Gary P |
ID-tag complexes, arrays, and methods of use thereof
|
US8084207B2
(en)
|
2005-03-03 |
2011-12-27 |
Ibis Bioscience, Inc. |
Compositions for use in identification of papillomavirus
|
US8182992B2
(en)
|
2005-03-03 |
2012-05-22 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious viruses
|
WO2006099365A2
(en)
|
2005-03-11 |
2006-09-21 |
Applera Corporation |
Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
|
CN101495647B
(zh)
|
2005-06-02 |
2014-12-17 |
阿德万德克斯公司 |
用于微生物分析的肽核酸探针
|
EP1919930B1
(de)
|
2005-07-01 |
2016-09-14 |
Dako Denmark A/S |
Neue nukleinsäure-basispaare
|
AU2006272776B2
(en)
|
2005-07-21 |
2012-01-19 |
Ibis Biosciences, Inc. |
Methods for rapid identification and quantitation of nucleic acid variants
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
DE602005003374T2
(de)
*
|
2005-10-17 |
2008-09-11 |
Pls-Design Gmbh |
Verfahren zur Bestimmung einer unbekannten PNS Seqenz und seine Verwendungen
|
US20070172842A1
(en)
*
|
2006-01-25 |
2007-07-26 |
Andreas Braun |
Methods for isolating and identifying novel target-specific structuremers for use in the biological sciences
|
US9388462B1
(en)
*
|
2006-05-12 |
2016-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
DNA sequencing and approaches therefor
|
EP2064332B1
(de)
|
2006-09-14 |
2012-07-18 |
Ibis Biosciences, Inc. |
Gezielte gesamtgenomamplifizierung zur identifizierung von krankheitserregern
|
EP2431483B1
(de)
|
2006-10-20 |
2015-04-01 |
Celera Corporation |
Mit venöser Thrombose assoziierte genetische Polymorphismen, Nachweisverfahren und deren Verwendungen
|
EP2069525A1
(de)
*
|
2006-12-29 |
2009-06-17 |
Applied Biosystems, LLC |
Systeme und verfahren für den nachweis von nukleinsäuren
|
EP2118310B1
(de)
*
|
2006-12-29 |
2013-03-06 |
Applied Biosystems, LLC |
Systeme und verfahren zum nachweis von nukleinsäuren
|
US20100172882A1
(en)
*
|
2007-01-11 |
2010-07-08 |
Glazer Peter M |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
WO2008104002A2
(en)
|
2007-02-23 |
2008-08-28 |
Ibis Biosciences, Inc. |
Methods for rapid forensic dna analysis
|
AU2008260029B2
(en)
|
2007-05-31 |
2015-02-12 |
Yale University |
A genetic lesion associated with cancer
|
US9598724B2
(en)
|
2007-06-01 |
2017-03-21 |
Ibis Biosciences, Inc. |
Methods and compositions for multiple displacement amplification of nucleic acids
|
EP3023436A1
(de)
|
2007-07-03 |
2016-05-25 |
Dako Denmark A/S |
Verbesserte verfahren zur herstellung, markierung und verwendung von mhc-multimeren
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
WO2009147537A2
(en)
|
2008-05-27 |
2009-12-10 |
Dako Denmark A/S |
Compositions and methods for detection of chromosomal aberrations with novel hybridization buffers
|
US20110212021A1
(en)
|
2008-05-30 |
2011-09-01 |
Slack Frank J |
Targeted oligonucleotide compositions for modifying gene expression
|
US8216786B2
(en)
|
2008-07-09 |
2012-07-10 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
|
EP2344893B1
(de)
|
2008-09-16 |
2014-10-15 |
Ibis Biosciences, Inc. |
Mikroplatten-handhabungssysteme und verfahren
|
EP2347254A2
(de)
|
2008-09-16 |
2011-07-27 |
Ibis Biosciences, Inc. |
Probenverarbeitungseinheiten, -systeme und damit verbundene verfahren
|
EP2349549B1
(de)
|
2008-09-16 |
2012-07-18 |
Ibis Biosciences, Inc. |
Mischpatronen, mischstationen und verwandte ausrüstungen, und system
|
EP2396803A4
(de)
|
2009-02-12 |
2016-10-26 |
Ibis Biosciences Inc |
Ionisationssondenanordnungen
|
US9303287B2
(en)
|
2009-02-26 |
2016-04-05 |
Dako Denmark A/S |
Compositions and methods for RNA hybridization applications
|
US8309356B2
(en)
*
|
2009-04-01 |
2012-11-13 |
Yale University |
Pseudocomplementary oligonucleotides for targeted gene therapy
|
JP2012531210A
(ja)
|
2009-06-25 |
2012-12-10 |
イェール ユニバ−シティ− |
Brca1における一塩基多型および癌のリスク
|
US8950604B2
(en)
|
2009-07-17 |
2015-02-10 |
Ibis Biosciences, Inc. |
Lift and mount apparatus
|
WO2011008972A1
(en)
|
2009-07-17 |
2011-01-20 |
Ibis Biosciences, Inc. |
Systems for bioagent identification
|
US20120215459A1
(en)
|
2009-09-04 |
2012-08-23 |
Marianne Stef |
High throughput detection of genomic copy number variations
|
WO2011027219A1
(en)
|
2009-09-04 |
2011-03-10 |
Progenika Biopharma, S.A. |
High throughput detection of small genomic deletions and insertions
|
EP3225695A1
(de)
|
2009-10-15 |
2017-10-04 |
Ibis Biosciences, Inc. |
Multiple-displacement-amplifikation
|
US20110268810A1
(en)
|
2009-11-02 |
2011-11-03 |
Yale University |
Polymeric materials loaded with mutagenic and recombinagenic nucleic acids
|
US8445228B2
(en)
|
2009-11-16 |
2013-05-21 |
Massachusetts Institute Of Technology |
Enhancement of in vitro translation by nanoparticle conjugates
|
EP2507391B1
(de)
|
2009-12-02 |
2016-08-17 |
Dako Denmark A/S |
Zusammensetzungen und verfahren zur hybridisierung ohne denaturierung
|
WO2011087789A2
(en)
|
2009-12-22 |
2011-07-21 |
Becton, Dickinson And Company |
Methods for the detection of microorganisms
|
AU2011215753B2
(en)
*
|
2010-02-11 |
2015-09-03 |
Nanostring Technologies, Inc. |
Compositions and methods for the detection of small RNAs
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
WO2011133803A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
US20110293585A1
(en)
|
2010-04-21 |
2011-12-01 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
US9327037B2
(en)
|
2011-02-08 |
2016-05-03 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
US9801948B2
(en)
|
2011-09-21 |
2017-10-31 |
Yale University |
Antimicrobial compositions and methods of use thereof
|
WO2013046033A1
(en)
|
2011-09-30 |
2013-04-04 |
Dako Denmark A/S |
Hybridization compositions and methods using formamide
|
US11118226B2
(en)
|
2011-10-21 |
2021-09-14 |
Agilent Technologies, Inc. |
Hybridization compositions and methods
|
WO2013082529A1
(en)
|
2011-12-02 |
2013-06-06 |
Yale University |
Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
|
US10465042B2
(en)
|
2011-12-02 |
2019-11-05 |
Yale University |
Poly(amine-co-ester) nanoparticles and methods of use thereof
|
US9895451B2
(en)
|
2011-12-02 |
2018-02-20 |
Yale University |
Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof
|
WO2013151771A1
(en)
|
2012-04-05 |
2013-10-10 |
Massachusetts Institute Of Technology |
Immunostimulatory compositions and methods of use thereof
|
WO2014033314A1
(en)
|
2012-09-03 |
2014-03-06 |
Uab Bioseka |
Antisense oligonucleotide targeting bacterial glucosyltransferases
|
EP2929050A1
(de)
|
2012-12-10 |
2015-10-14 |
AdvanDx, Inc. |
Verwendung von sonden zur massenspektrometrischen identifizierung von mikroorganismen oder zellen und relevanten erkrankungen von interesse
|
WO2014113802A1
(en)
|
2013-01-18 |
2014-07-24 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS
|
SG10201710369RA
(en)
|
2013-03-15 |
2018-01-30 |
Techulon Inc |
Antisense molecules for treatment of staphylococcus aureus infection
|
EP2970976A4
(de)
|
2013-03-15 |
2016-11-02 |
Techulon Inc |
Antisense-moleküle zur behandlung von staphylococcus-aureus-infektionen
|
EP3808338A1
(de)
|
2013-09-11 |
2021-04-21 |
Eagle Biologics, Inc. |
Flüssige proteinformulierungen mit ionischen flüssigkeiten
|
LT6214B
(lt)
|
2013-10-07 |
2015-08-25 |
Uab "Bioseka" |
Priešprasminiai oligonukleotidai aterosklerozės ir kardiovaskulinių infekcijų prevencijai
|
WO2015057998A1
(en)
|
2013-10-16 |
2015-04-23 |
The University Of British Columbia |
Device for formulating particles at small volumes
|
JP2016535781A
(ja)
|
2013-11-03 |
2016-11-17 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
経皮薬物送達のためのイオン性液体
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
US10272019B2
(en)
|
2014-05-09 |
2019-04-30 |
Yale University |
Topical formulation of hyperbranched polyglycerol-coated particles thereof
|
WO2015175545A1
(en)
|
2014-05-12 |
2015-11-19 |
The Johns Hopkins University |
Highly stable biodegradable gene vector platforms for overcoming biological barriers
|
JP6763780B2
(ja)
|
2014-05-12 |
2020-09-30 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
合成脳浸透遺伝子ベクターの操作
|
WO2016054259A1
(en)
|
2014-10-01 |
2016-04-07 |
Arsia Therapeutics, Inc. |
Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
|
US10682422B2
(en)
|
2014-11-18 |
2020-06-16 |
Yale University |
Formulations for targeted release of agents under low pH conditions and methods of use thereof
|
WO2016081621A1
(en)
|
2014-11-18 |
2016-05-26 |
Yale University |
Formulations for targeted release of agents under low ph conditions and methods of use thereof
|
US20180126014A1
(en)
|
2015-04-15 |
2018-05-10 |
Yale University |
Compositions for enhancing delivery of agents across the blood brain barrier and methods of use thereof
|
AU2016385135B2
(en)
|
2016-01-06 |
2022-02-17 |
The University Of British Columbia |
Bifurcating mixers and methods of their use and manufacture
|
AU2017207341A1
(en)
|
2016-01-12 |
2018-08-02 |
Interleukin Genetics, Inc. |
Methods for predicting response to treatment
|
JP2019508037A
(ja)
|
2016-02-16 |
2019-03-28 |
イェール ユニバーシティーYale Universit |
標的化遺伝子編集を増強するための組成物およびその使用方法
|
US20200308590A1
(en)
|
2016-02-16 |
2020-10-01 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
WO2017147594A1
(en)
|
2016-02-26 |
2017-08-31 |
Yale University |
COMPOSITIONS AND METHODS OF USING piRNAS IN CANCER DIAGNOSTICS AND THERAPEUTICS
|
US20190117799A1
(en)
|
2016-04-01 |
2019-04-25 |
The Brigham And Women's Hospital, Inc. |
Stimuli-responsive nanoparticles for biomedical applications
|
WO2017197128A1
(en)
|
2016-05-11 |
2017-11-16 |
Yale University |
Poly(amine-co-ester) nanoparticles and methods of use thereof
|
EP3503927A1
(de)
|
2016-08-29 |
2019-07-03 |
The Regents of the University of California |
Topische formulierungen auf basis von ionischen spezies zur hautbehandlung
|
EP3519578B1
(de)
|
2016-10-03 |
2021-12-22 |
Precision Nanosystems Inc |
Zusammensetzungen zur transfektion von resistenten zelltypen
|
US20200085758A1
(en)
|
2016-12-16 |
2020-03-19 |
The Brigham And Women's Hospital, Inc. |
Co-delivery of nucleic acids for simultaneous suppression and expression of target genes
|
EP3554556B1
(de)
|
2016-12-19 |
2022-03-09 |
Ventana Medical Systems, Inc. |
Peptid-nukleinsäure-konjugate
|
US10329620B2
(en)
|
2017-01-12 |
2019-06-25 |
Cardioforecast Ltd. |
Methods and kits for treating cardiovascular disease
|
US20200113821A1
(en)
|
2017-04-04 |
2020-04-16 |
Yale University |
Compositions and methods for in utero delivery
|
WO2019032827A1
(en)
|
2017-08-09 |
2019-02-14 |
Massachusetts Institute Of Technology |
PEPTIDE ALBUMIN BINDING CONJUGATES AND METHODS THEREOF
|
US10953036B2
(en)
|
2017-11-20 |
2021-03-23 |
University Of Georgia Research Foundation, Inc. |
Compositions and methods of modulating HIF-2A to improve muscle generation and repair
|
WO2019120635A1
(en)
|
2017-12-18 |
2019-06-27 |
Ventana Medical Systems, Inc. |
Peptide nucleic acid conjugates
|
US20190298857A1
(en)
|
2018-01-09 |
2019-10-03 |
Trucode Gene Repair, Inc. |
Polymer-based nanoparticles, related formulations methods, and apparatus
|
US20210315820A1
(en)
|
2018-07-30 |
2021-10-14 |
Trucode Gene Repair, Inc. |
Lipid nanoparticle formulations comprising nucleic acid mimics
|
EP3830278A4
(de)
|
2018-08-01 |
2022-05-25 |
University of Georgia Research Foundation, Inc. |
Zusammensetzungen und verfahren zur verbesserung der embryoentwicklung
|
US20210189431A1
(en)
|
2018-08-10 |
2021-06-24 |
Yale University |
Compositions and methods for embryonic gene editing in vitro
|
MX2021002266A
(es)
|
2018-08-31 |
2021-05-27 |
Univ Yale |
Composiciones y metodos para aumentar la edicion de genes basados en nucleasa y triplex.
|
WO2020112195A1
(en)
|
2018-11-30 |
2020-06-04 |
Yale University |
Compositions, technologies and methods of using plerixafor to enhance gene editing
|
US11814464B2
(en)
|
2019-04-29 |
2023-11-14 |
Yale University |
Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof
|
US20220249660A1
(en)
|
2019-06-06 |
2022-08-11 |
Sitokine Limited |
Compositions and methods for treating lung, colorectal and breast cancer
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
WO2020257779A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
US20220280656A1
(en)
|
2019-07-31 |
2022-09-08 |
Yale University |
Compositions and methods for treating sickle cell disease
|
WO2021028469A1
(en)
|
2019-08-12 |
2021-02-18 |
Sitokine Limited |
Compositions and methods for treating cytokine release syndrome and neurotoxicity
|
CA3149421A1
(en)
|
2019-08-30 |
2021-03-04 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
WO2021205013A1
(en)
|
2020-04-09 |
2021-10-14 |
Sitokine Limited |
Compositions and methods for treating covid-19
|
AU2021293780A1
(en)
|
2020-06-19 |
2023-02-02 |
Yale University |
Poly(amine-co-ester) polymers with modified end groups and enhanced pulmonary delivery
|
MX2023002480A
(es)
|
2020-08-31 |
2023-05-18 |
Univ Yale |
"composiciones y métodos para el suministro de ácidos nucleicos a las células.
|
CN112557640B
(zh)
*
|
2020-12-28 |
2022-07-19 |
中蓝晨光化工有限公司 |
一种缩合型硅树脂取代度的测试方法
|
WO2023159189A1
(en)
|
2022-02-18 |
2023-08-24 |
Yale University |
Branched poly(amine-co-ester) polymers for more efficient nucleic expression
|